Ascom wins its biggest Ascom Myco 3 smartphone order

May 21, 2019

Ascom and British mobile care monitoring specialist Person Centred Software have signed joint contract with a value of about CHF 3.5 million that put state-of-the-art Ascom smartphones in the hands of several thousand care home staff across the UK.The order for Ascom Myco 3 smartphones has a volume of several thousand units.

The 18-month reseller agreement for the devices plus accessories between mobile care monitoring specialist Person Centred Software and Ascom is set to transform care for residents, integrating technology and driving up standards.

Ascom's Myco 3 smartphone will become the standard device for staff in 1,200 care homes already using Person Centred Software's mobile care monitoring products. The contract will also allow Person Centred Software to offer Ascom Myco 3s as replacements for Apple devices currently being used in other care homes.

Paul Lawrence, Managing Director of Ascom UK, says: "We are delighted that a major player in the care home sector has joined with us to offer integration of state-of-the-art technology from both companies. Person Centred Software wants to offer highly responsive care to residents by gathering and analyzing data from multiple sources more intelligently. Ascom Myco 3 will enable them to do that, while allowing staff to better manage their workload. Together, we can help care homes to provide better care through digital transformation."

Jonathan Papworth, Co-Founder and Director of Person Centred Software, says: "We are excited to partner with Ascom to help care homes realize the benefits of using innovative technology. Care homes using Ascom Myco 3 handsets will have the opportunity to integrate evidence of care with other systems to provide a universal mobile device for everyone involved in the provision of care."

This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).